PATENT CLAIM ANALYSIS

Application Number: 16000962
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["382", "131000"]

Abstract:
A method of treating cardiac arrhythmia in a heart, including (i) determining that cardiac tissue is viable but with reduced innervation; and (ii) ablating the tissue to reduce a prevalence of arrhythmia in said heart. Optionally, the determining comprises detecting portions of heart wall which lack electrical activity. Optionally, at least some tissue which is viable but lacks nervous control is ablated, for example, to reduce or avoid arrhythmia.

Claim (Index 9):
The method of  claim 1 , wherein:\n the autonomic nervous control of the portions of the organ with vital non-neural tissue and reduced autonomic nervous control is reduced relative to a normal level of autonomic nervous control; and wherein the normal level of autonomic nervous control is provided by an indication of one or more parameter ranges of normal autonomic nervous control comprising at least one of the group consisting of:\n a map of normal autonomic nervous control activity ranges allowed for imaged portions of the organ, and \n one or more thresholds of autonomic nervous control activity for different parts of the organ.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 94.0
- Lexical Diversity: 1.54717
- Patent Class: 382.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14917285', '14762933', '15110756', '12910424', '13008644']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.2693112827493232
- 35 USC 102 Novelty (BERT): 0.5582794826911838
- Combined Prediction Score: 0.2982081027435093
- Mean Citation Score: 232.95332
- Max Citation Score: 413.3069
- Similarity Product: 378.1159346569657

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test